Seeking Alpha

EXEL
  Exelixis, Inc. - NASDAQ

9/30/2014, 9:40 PM ET
  • Chemistfrog | Send Message 28 Sep 2012

    EXEL should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $EXEL
    Reply
      EXEL vs. ETF Alternatives
      Company Description
      Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States